?Efficacy of prebiotic products on admitted patients with Covid-19

Evaluation of probiotic use on control of sign and symptoms of admitted patients with covid-19

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20161206031255N4

Enrollment

Registered

2020-12-07

Start date

2020-09-22

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

covid 19. COVID-19, virus identified

Interventions

Intervention 1: Intervention group: Patients take standard medicine hydroxychlroquine and remdecevir. prebiotic powder 150 mg in the pack that 3 mg per dose for three times a day for 2 weeks. Interven

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Informed consent positive PCR or positive CT-scan

Exclusion criteria

Exclusion criteria: Patient's unwillingness to participate Dialysis patients ICU admitted or intubated patients Pregnancy orbreast feeding use of steroid or immunosupressive medicatns use of the other herbal medications

Design outcomes

Primary

Measure	Time frame
Cough. Timepoint: Daily. Method of measurement: By question from the patient.;Breath rate. Timepoint: Four times in a day. Method of measurement: physical exam.;Fever. Timepoint: Four times in a day. Method of measurement: physical exam.;Weakness. Timepoint: daily. Method of measurement: examination.;Myalgia. Timepoint: daily. Method of measurement: history.;C reactive protein. Timepoint: Daily. Method of measurement: Blood lab.;Lymphocyte. Timepoint: Daily. Method of measurement: Blood lab.;Blood Oxygen saturation. Timepoint: four times in a day. Method of measurement: physical examination.;Diarrhea. Timepoint: daily. Method of measurement: Ask from patient.	—

Measure

Time frame

Cough. Timepoint: Daily. Method of measurement: By question from the patient.;Breath rate. Timepoint: Four times in a day. Method of measurement: physical exam.;Fever. Timepoint: Four times in a day. Method of measurement: physical exam.;Weakness. Timepoint: daily. Method of measurement: examination.;Myalgia. Timepoint: daily. Method of measurement: history.;C reactive protein. Timepoint: Daily. Method of measurement: Blood lab.;Lymphocyte. Timepoint: Daily. Method of measurement: Blood lab.;Blood Oxygen saturation. Timepoint: four times in a day. Method of measurement: physical examination.;Diarrhea. Timepoint: daily. Method of measurement: Ask from patient.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRoshanak Mokaberinejad

Shahid Beheshti University of Medical Sciences

Rmokaberinejad@gmail.com+98 21 8877 2135

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026